Novo Nordisk transfers Parkinson's cell therapy to Cellular Intelligence
AI Summary
Novo Nordisk has transferred its Parkinson's cell therapy to Cellular Intelligence, indicating a strategic move within the healthcare industry. Details regarding the implications of this transfer on research and development are yet to be disclosed.